Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
about
Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinomaIncreased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.Stathmin is a potential molecular marker and target for the treatment of gastric cancer.Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancerThyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinomaAn underlying prognosis predictor of hepatocellular carcinoma: Oncoprotein 18.Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis.Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.
P2860
Q28540910-569C5800-30F1-47C3-8594-C2706C333589Q33728805-530522A8-E7CC-439A-B29A-0F084EAD79C9Q34217592-58FEAA5D-E2AB-4CD1-ABA5-E7EF692606F7Q34606433-C94942C8-C3EF-4CB0-A38C-3F17FDDBA6EDQ35791697-21C93377-9510-4D7D-B1D9-469CF018BA25Q36642789-14BDC8C5-71A5-46C7-A780-A739EB47DA25Q36900849-83403AA1-E898-4B80-AF8B-A6188232B159Q37487309-88EB7C37-B6D8-4DE7-8043-CC7234BDDD7EQ37565193-1D58E492-76A5-46A2-9BFA-DAA6150B8294Q37694739-8662EBCC-41F9-4EA9-BDD6-147CCE553E0BQ37716616-66CF7597-95B9-4160-AB2C-33866878660CQ38729446-86A3650D-F824-434E-A698-A18DB9C4819CQ38993024-D55C98B8-4666-4E88-9335-1B884A06B4C5Q47172693-08356F11-ECD8-4CFF-8332-B58ACE2B1A21Q52632024-1EA7AAEB-121A-4A1B-BB4A-52C568BD696CQ52688051-474B9AD6-F860-4A87-BE3F-03007981D9D6
P2860
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@en
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@nl
type
label
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@en
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@nl
prefLabel
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@en
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@nl
P2093
P1433
P1476
Up-regulated expression of stathmin may be associated with hepatocarcinogenesis.
@en
P2093
Xiaonan Kang
Yinkun Liu
P304
P577
2010-04-01T00:00:00Z